During the past decade, Digestive Disease Associates conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Digestive Disease Associates" are "Ulcerative Colitis" (5 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Digestive Disease Associates" in a lesser frequency.

Most popular intervention types in "Digestive Disease Associates" are "Drug" (6 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ontamalimab" (4 trials), "Placebo" (4 trials), "25 mg Ontamalimab" (1 trials), "75 mg Ontamalimab" (1 trials) and "Mirikizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Digestive Disease Associates" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Digestive Disease Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Digestive Disease Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Digestive Disease Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".